Landmark preclinical study cured lung metastases in 50 percent of breast cancers by making nanoparticles inside the tumor
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology.
The majority of cancer deaths are due to metastases to the lung and liver, yet there is no cure. Existing cancer drugs provide limited benefit due to their inability to overcome biological barriers in the body and reach the cancer cells in sufficient concentrations. Houston Methodist nanotechnology and cancer researchers have solved this problem by developing a drug that generates nanoparticles inside the lung metastases in mice.
In this study, 50 percent of the mice treated with the drug had no trace of metastatic disease after eight months. That’s equivalent to about 24 years of long-term survival following metastatic disease for humans.
Due to the body’s own defense mechanisms, most cancer drugs are absorbed into healthy tissue causing negative side effects, and only a fraction of the administered drug actually reaches the tumor, making it less effective, said Mauro Ferrari, Ph.D, president and CEO of the Houston Methodist Research Institute. This new treatment strategy enables sequential passage of the biological barriers to transport the killing agent into the heart of the cancer. The active drug is only released inside the nucleus of the metastatic disease cell, avoiding the multidrug resistance mechanism of the cancer cells. This strategy effectively kills the tumor and provides significant therapeutic benefit in all mice, including long-term survival in half of the animals.
This finding comes 20 years after Ferrari started his work in nanomedicine. Ferrari and Haifa Shen, M.D., Ph.D., are co-senior authors on the paper, which describes the action of the injectable nanoparticle generator (iNPG), and how a complex method of transporting a nano-version of a standard chemotherapy drug led to never before seen results in mice models with triple negative breast cancer that had metastasized to the lungs.
“This may sound like science fiction, like we’ve penetrated and destroyed the Death Star, but what we discovered is transformational. We invented a method that actually makes the nanoparticles inside the cancer and releases the drug particles at the site of the cellular nucleus. With this injectable nanoparticle generator, we were able to do what standard chemotherapy drugs, vaccines, radiation, and other nanoparticles have all failed to do,” said Ferrari.
Houston Methodist has developed good manufacturing practices (GMP) for this drug and plans to fast-track the research to obtain FDA-approval and begin safety and efficacy studies in humans in 2017.
“I would never want to overpromise to the thousands of cancer patients looking for a cure, but the data is astounding,” said Ferrari, senior associate dean and professor of medicine, Weill Cornell Medicine. “We’re talking about changing the landscape of curing metastatic disease, so it’s no longer a death sentence.”
The Latest on: Injectable nanoparticle generator
via Google News
The Latest on: Injectable nanoparticle generator
- The Future Of Diesel Is On Shaky Groundon May 8, 2020 at 5:00 pm
Diesel is a fuel that has had a mixed history, with varying levels of take-up by consumers around the world. In the world of transport, diesel engines have offered better fuel economy and torque ...
- Molecules (Basel, Switzerland)on May 5, 2020 at 5:00 pm
Studying and Modeling of the Extraction Properties of the Natural Deep Eutectic Solvent and Sorbitol-Based Solvents in Regard to Biologically Active Substances from Glycyrrhizae Roots.
- Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine modelon May 4, 2020 at 2:15 am
This Methods section describes the established SOP. Pigs were sedated with an intramuscular injection of ketamine (2 mg/kg), xylazine (2 mg/kg) and telazol (4 mg/kg), intubated, and ...
- 3D Printering: Wherein ABS Is Dangerouson April 30, 2020 at 5:00 pm
After getting a baseline measurement of nanoparticles with this very expensive ... They worked on ABS injection molding machines every day, and when comparing the pre-exposure conditions between ...
- In-situ resonant band engineering of solution-processed semiconductors generates high performance n-type thermoelectric nano-inkson April 29, 2020 at 2:25 am
With the worldwide demand for energy and thermal management rapidly accelerating, thermoelectric (TE) devices, which can convert thermal energy to electrical energy (and vice versa), are receiving ...
- Mohammad Haideron January 23, 2020 at 10:38 am
His research interests include low-power analog and RF circuit design for sensor applications, bioamplifiers, neuromorphic architecture, energy-efficient biomedical telemetry, low-power signal ...
- Nanotechnology Companies in the USAon May 28, 2018 at 8:23 pm
The company originally pioneered use of encapsulated ingredients and nanoparticles for sunscreens and personal ... Develops and sells patented high performance, injection-molded nanospray devices for ...
- Injection Rate Control Deviceon February 20, 2018 at 3:29 am
Description: -selling TEOS vaporization system models Combines SEF or LF, and digital control is possible No need for a special bubbling tank or vaporization tank Line-up of DeviceNetTM model RoHS ...
- Low Pressure Injection Molding Equipmenton February 19, 2018 at 4:02 pm
Description: TMP Technologies specializes in foam conversion, as well as the fabrication and assembly of close tolerance, engineered components utilizing various materials. Our manufacturing ...
via Bing News